data_PRD_000206 # _pdbx_reference_molecule.prd_id PRD_000206 _pdbx_reference_molecule.name "VANCOMYCIN AGLYCON" _pdbx_reference_molecule.represent_as polymer _pdbx_reference_molecule.type Oligopeptide _pdbx_reference_molecule.type_evidence_code ? _pdbx_reference_molecule.class Antibiotic _pdbx_reference_molecule.class_evidence_code ? _pdbx_reference_molecule.formula "C53 H52 Cl2 N8 O17" _pdbx_reference_molecule.formula_weight 1143.929 _pdbx_reference_molecule.chem_comp_id ? _pdbx_reference_molecule.release_status REL _pdbx_reference_molecule.replaces ? _pdbx_reference_molecule.replaced_by ? _pdbx_reference_molecule.compound_details ;VANCOMYCIN IS A TRICYCLIC GLYCOPEPTIDE. THE SCAFFOLD IS A HEPTAPEPTIDE WITH THE CONFIGURATION D-D-L-D-D-L-L. IT IS FURTHER GLYCOSYLATED BY A DISACCHARIDE MADE OF D-GLUCOSE AND VANCOSAMINE. HERE, VANCOMYCIN AGLYCON IS REPRESENTED BY SEQUENCE (SEQRES) ; _pdbx_reference_molecule.description "VANCOMYCIN AGLYCON IS THE NONSUGAR COMPONENT OF VANCOMYCIN, CONSISTING OF THE TRICYCLIC HEPTAPEPTIDE ONLY." _pdbx_reference_molecule.representative_PDB_id_code 1ghg # _pdbx_reference_entity_list.prd_id PRD_000206 _pdbx_reference_entity_list.ref_entity_id 1 _pdbx_reference_entity_list.component_id 1 _pdbx_reference_entity_list.type polymer _pdbx_reference_entity_list.details "PEPTIDE LIKE SEQUENCE RESIDUES 1 TO 7" # loop_ _pdbx_reference_entity_poly_link.prd_id _pdbx_reference_entity_poly_link.ref_entity_id _pdbx_reference_entity_poly_link.link_id _pdbx_reference_entity_poly_link.atom_id_1 _pdbx_reference_entity_poly_link.comp_id_1 _pdbx_reference_entity_poly_link.entity_seq_num_1 _pdbx_reference_entity_poly_link.atom_id_2 _pdbx_reference_entity_poly_link.comp_id_2 _pdbx_reference_entity_poly_link.entity_seq_num_2 _pdbx_reference_entity_poly_link.value_order _pdbx_reference_entity_poly_link.component_id _pdbx_reference_entity_poly_link.details _pdbx_reference_entity_poly_link.insert_code_1 _pdbx_reference_entity_poly_link.insert_code_2 PRD_000206 1 1 C MLU 1 N OMZ 2 sing 1 ? ? ? PRD_000206 1 2 C OMZ 2 N ASN 3 sing 1 ? ? ? PRD_000206 1 3 OH OMZ 2 C5 GHP 4 sing 1 ? ? ? PRD_000206 1 4 C ASN 3 N GHP 4 sing 1 ? ? ? PRD_000206 1 5 C GHP 4 N GHP 5 sing 1 ? ? ? PRD_000206 1 6 C3 GHP 4 OCZ OMY 6 sing 1 ? ? ? PRD_000206 1 7 C GHP 5 N OMY 6 sing 1 ? ? ? PRD_000206 1 8 C3 GHP 5 CG1 3FG 7 sing 1 ? ? ? PRD_000206 1 9 C OMY 6 N 3FG 7 sing 1 ? ? ? # _pdbx_reference_entity_poly.prd_id PRD_000206 _pdbx_reference_entity_poly.ref_entity_id 1 _pdbx_reference_entity_poly.db_code NOR00681 _pdbx_reference_entity_poly.db_name NOR _pdbx_reference_entity_poly.type peptide-like # _pdbx_reference_entity_sequence.prd_id PRD_000206 _pdbx_reference_entity_sequence.ref_entity_id 1 _pdbx_reference_entity_sequence.type peptide-like _pdbx_reference_entity_sequence.NRP_flag Y # loop_ _pdbx_reference_entity_poly_seq.prd_id _pdbx_reference_entity_poly_seq.ref_entity_id _pdbx_reference_entity_poly_seq.num _pdbx_reference_entity_poly_seq.mon_id _pdbx_reference_entity_poly_seq.parent_mon_id _pdbx_reference_entity_poly_seq.hetero _pdbx_reference_entity_poly_seq.observed PRD_000206 1 1 MLU LEU N Y PRD_000206 1 2 OMZ TYR N Y PRD_000206 1 3 ASN ASN N Y PRD_000206 1 4 GHP PHE N Y PRD_000206 1 5 GHP PHE N Y PRD_000206 1 6 OMY TYR N Y PRD_000206 1 7 3FG PHE N Y # loop_ _pdbx_prd_audit.prd_id _pdbx_prd_audit.date _pdbx_prd_audit.processing_site _pdbx_prd_audit.action_type PRD_000206 2012-02-03 RCSB "Create molecule" PRD_000206 2012-07-09 PDBE "Other modification" PRD_000206 2012-12-12 RCSB "Initial release" PRD_000206 2013-06-03 RCSB "Other modification" PRD_000206 2017-05-04 RCSB "Other modification" PRD_000206 2020-07-29 RCSB "Other modification" PRD_000206 2023-09-20 PDBE "Modify audit" #